- Home
- LODE vs MIST Comparison
LODE vs MIST Comparison
Compare LODE & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LODE
- MIST
- Stock Information
- Founded
- LODE 2008
- MIST 2003
- Country
- LODE United States
- MIST Canada
- Employees
- LODE N/A
- MIST N/A
- Industry
- LODE Major Chemicals
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- LODE Industrials
- MIST Health Care
- Exchange
- LODE Nasdaq
- MIST Nasdaq
- Market Cap
- LODE 53.0M
- MIST 53.9M
- IPO Year
- LODE N/A
- MIST N/A
- Fundamental
- Price
- LODE $3.04
- MIST $1.73
- Analyst Decision
- LODE Buy
- MIST Strong Buy
- Analyst Count
- LODE 1
- MIST 2
- Target Price
- LODE $26.00
- MIST $9.50
- AVG Volume (30 Days)
- LODE 489.5K
- MIST 947.9K
- Earning Date
- LODE 05-08-2025
- MIST 05-14-2025
- Dividend Yield
- LODE N/A
- MIST N/A
- EPS Growth
- LODE N/A
- MIST N/A
- EPS
- LODE N/A
- MIST N/A
- Revenue
- LODE $3,376,027.00
- MIST N/A
- Revenue This Year
- LODE $33.58
- MIST N/A
- Revenue Next Year
- LODE N/A
- MIST N/A
- P/E Ratio
- LODE N/A
- MIST N/A
- Revenue Growth
- LODE 102.20
- MIST N/A
- 52 Week Low
- LODE $1.26
- MIST $0.63
- 52 Week High
- LODE $10.10
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- LODE 60.74
- MIST 69.51
- Support Level
- LODE $2.86
- MIST $1.39
- Resistance Level
- LODE $3.37
- MIST $1.60
- Average True Range (ATR)
- LODE 0.21
- MIST 0.12
- MACD
- LODE 0.03
- MIST 0.05
- Stochastic Oscillator
- LODE 70.27
- MIST 95.38
About LODE Comstock Inc.
Comstock Inc innovates and commercializes technologies that are deployable across entire industries to contribute to energy abundance by efficiently extracting and converting under-utilized natural resources, such as waste and other forms of woody biomass into renewable fuels, and end-of-life electronics into recovered electrification metals. Comstock's innovations group is engaged in developing and using artificial intelligence technologies for advanced materials development.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).